WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Hang Fai Kwok
PeerJ Editor, Author & Reviewer
630 Points

Contributions by role

Author 100
Reviewer 60
Editor 470

Contributions by subject area

Biochemistry
Gastroenterology and Hepatology
Oncology
Translational Medicine
Histology
Cardiology
Pharmacology
Bioinformatics
Genomics
Biodiversity
Cell Biology
Toxicology
Drugs and Devices
Molecular Biology
Respiratory Medicine
Otorhinolaryngology
Immunology
Medical Genetics

Hang Fai Kwok

PeerJ Editor, Author & Reviewer

Summary

Prof Kwok’s research interests mainly focus on the development of novel monoclonal antibodies and venom-based peptides as prototype drugs for anticancer and anti-inflammatory therapies. In addition, Prof. Kwok’s research group is also expanding scientific knowledge and research in the areas of existing and novel cancer biomarkers such as 1) matricellular protein — OPN, 2) metalloproteinase — ADAM17 & ADAMTS5, 3) DNA replication licensing factor — MCM proteins, 4) small GTP binding protein — RAN, as well as immunotherapy markers (e.g. PD-1/PD-L1) in order to identify and validate their prognostic and therapeutic values according to the roles in hallmarks of cancer.

Immunology Molecular Biology Oncology Pharmacology Translational Medicine

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Past or current institution affiliations

University of Macau

Work details

Professor & Associate Head of Department

University of Macau
Department of Biomedical Sciences, Faculty of Health Sciences
Key Research Areas: Novel Therapeutic Antibodies Development, Venom-based Peptide & Natural Biomolecule Prototype Drugs Development, Cancer Biomarkers & Immunotherapy Markers Discovery for Prognostic and Therapeutic Validation

Websites

  • Google Scholar

PeerJ Contributions

  • Articles 1
  • Edited 3
July 19, 2017
DAPK1 as an independent prognostic marker in liver cancer
Ling Li, Libin Guo, Qingshui Wang, Xiaolong Liu, Yongyi Zeng, Qing Wen, Shudong Zhang, Hang Fai Kwok, Yao Lin, Jingfeng Liu
https://doi.org/10.7717/peerj.3568 PubMed 28740751

Academic Editor on

July 26, 2022
RNA-binding protein CELF6 modulates transcription and splicing levels of genes associated with tumorigenesis in lung cancer A549 cells
HuSai Ma, GuoWei Liu, Bin Yu, Joshua Wang, YaLi Qi, YiYing Kou, Ying Hu, ShunJun Wang, Fei Wang, Dong Chen
https://doi.org/10.7717/peerj.13800 PubMed 35910766
July 6, 2022
Evaluation of potential anti-metastatic and antioxidative abilities of natural peptides derived from Tecoma stans (L.) Juss. ex Kunth in A549 cells
Sucheewin Krobthong, Yodying Yingchutrakul, Wattanapong Sittisaree, Tatpong Tulyananda, Pawitrabhorn Samutrtai, Kiattawee Choowongkomon, Udom Lao-On
https://doi.org/10.7717/peerj.13693 PubMed 35818360
January 5, 2022
Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma
Chaozhi Yang, Xuebing Wang, Chenjie Qiu, Ziruo Zheng, Kai Lin, Min Tu, Kai Zhang, Kuirong Jiang, Wentao Gao
https://doi.org/10.7717/peerj.12736 PubMed 35036176